(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents.
Contents:
Extrapolation of Preclinical Data into Clinical Reality - Translational Science.- Smarter Candidate Selection - Utilizing Microdosing in Exploratory Clinical Studies.- The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes.- Using Exposure - Response and Biomarkers to Streamline Early Drug Development.- Experiences with Dose Finding in Patients in Early Drug Development: The Use of Biomarkers in Early Decision Making.- Genotype and Phenotype Relationship in Drug Metabolism.- Clinical Trials in Elderly Patients.- Dose Finding in Pediatric Patients.- Integration of Pediatric Aspects into the General Drug Development Process.- Current Stumbling Blocks in Oncology Drug Development.- Exploratory IND: A New Regulatory Strategy for Early Clinical Drug Development in the United States.- Ethnic Aspects of Cancer Trials in Asia.- Evaluation of the Effect on Cardiac Repolarization (QTc Interval) of Oncologic Drugs.- The Role of PET Scanning in Determining Pharmacoselective Doses in Oncology Drug Development.- Biometrical Aspects of Drug Development.- Preventing Postmarketing Changes in Recommended Doses and Marketing Withdrawals.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: November, 2014
Pages: 240
Weight: 318g
Availability: Available
Subcategories: Biochemistry, General Practice, Pharmacology
Publisher recommends
From the same series
Harald Renz
Alexei Bogdanov
W Wohlleben
P.H. Seeberger
P.A. Schubiger
Bernhard Haendler
Eugene Butcher
Kenneth S. Korach
Shelley L. Berger
H. Graf
John Morser
Heinz-Peter Schultheiss
Andreas Radbruch
S. Bernhard
R. Krattenmacher
Lechoslaw Turski
R.B. Lichtner
H. Graf
Ulrich Dirnagl
I. Schlichting
Kristof Chwalisz
A. Rosenthal
Richard Horuk
Khusru Asadullah
Hinrich Gronemeyer
J. Lindenmann
Eberhard Nieschlag
Robert E. Sobol
U.-F. Habenicht
Markus Schwaiger
R.G.G. Russell
F. Diederich
H. Seidel
Herbert Waldmann
H. Kettenmann
J.A. Dormandy
O. Pelkonen
V. Hansson
Martin Tenniswood
K. Beyreuther
W. Sterry
Peter H. Seeburg
C.N. Serhan
C. Bezold
Jack R. Jr. Lancaster
A. Haverich
Kenneth S. Korach
C. Nüsslein-Volhard
John Eppig
Reinhard Ziegler
E.C. Herrmann
Erwin F. Wagner
A. Cockburn
Peter Ramwell
Orla M. Conneely
Guido Kroemer
Burkhart Schraven
Bernhard Haendler
Manfred T. Reetz
Bernhard Haendler
Guido Kroemer
Stefan Jaroch
Orla M. Conneely
Burkhart Schraven
Bernhard Haendler
Andreas Radbruch
P.H. Seeberger
Kenneth S. Korach
B. Weiss
P.A. Schubiger
John Morser
Stefan Jaroch
Shelley L. Berger